Financial Performance - For the nine months ended September 30, 2023, the group's unaudited revenue was approximately SGD 7.6 million, a decrease of about SGD 4.2 million or 35.6% compared to SGD 11.8 million for the same period in 2022[5] - The group recorded an unaudited loss of approximately SGD 3.4 million for the nine months ended September 30, 2023, compared to a loss of approximately SGD 1.0 million for the same period in 2022[5] - Basic loss per share for the nine months ended September 30, 2023, was SGD 0.58, compared to SGD 0.18 for the same period in 2022[6] - The group's gross profit for the nine months ended September 30, 2023, was SGD 126,000, down from SGD 1.3 million in the same period in 2022[6] - Operating loss for the nine months ended September 30, 2023, was SGD 3.3 million, compared to SGD 855,000 for the same period in 2022[6] - Total comprehensive loss for the nine months ended September 30, 2023, was SGD 3.5 million, compared to SGD 1.1 million for the same period in 2022[9] - The group reported a net loss attributable to equity holders of the company of SGD 3.3 million for the nine months ended September 30, 2023, compared to SGD 933,000 for the same period in 2022[9] - Revenue for the nine months ended September 30, 2023, was SGD 7,621,000, a decrease of 35.5% compared to SGD 11,825,000 for the same period in 2022[19] - Sales of goods amounted to SGD 7,283,000, down 37.5% from SGD 11,601,000 in the previous year[19] - The company reported a loss attributable to equity holders of SGD 3,282,000, compared to a loss of SGD 933,000 in the same period last year[33] - Basic loss per share for the nine months was SGD 0.58, compared to SGD 0.18 in 2022[33] - The net loss for the nine months ended September 30, 2023, was approximately SGD 3.4 million, compared to a net loss of approximately SGD 1.0 million for the same period last year, indicating an increase in losses due to a decrease in sales orders for disposable medical device components[41] - The overall gross profit decreased by approximately SGD 1.2 million or 92.3% to approximately SGD 0.1 million, with the gross profit margin dropping from approximately 11.0% to about 1.7%[46] Expenses and Costs - The company had no potential ordinary shares in issue during the period, resulting in no diluted loss per share for both periods[5] - The group’s administrative expenses increased to SGD 2.3 million for the nine months ended September 30, 2023, from SGD 1.9 million in the same period in 2022[6] - Other income decreased to SGD 78,000 from SGD 107,000, with government grants contributing SGD 29,000 and waste sales contributing SGD 49,000[20] - Total expenses for the nine months were SGD 10,512,000, a reduction of 18.8% from SGD 12,950,000 in 2022[22] - Cost of goods sold was SGD 7,495,000, down 28.8% from SGD 10,523,000 in the previous year[22] - Administrative expenses increased by approximately SGD 0.4 million or 21.1% to approximately SGD 2.3 million, primarily due to increased research and development costs and rising utility expenses from global natural gas and oil price increases[48][49] - Sales costs decreased by approximately SGD 3.0 million or 28.6% to approximately SGD 7.5 million, aligning with the decrease in revenue[45] - The company incurred finance costs of SGD 115,000, slightly up from SGD 110,000 in the previous year[23] Dividends and Corporate Governance - The board of directors did not recommend the payment of dividends for the nine months ended September 30, 2023, consistent with the previous year[5] - The company did not declare an interim dividend for the nine months ended September 30, 2023, consistent with the previous year[37] - The company has complied with the corporate governance code, except for the separation of roles between the chairman and CEO, which is currently held by the same individual[65] - The audit committee, consisting of three independent non-executive directors, reviewed the unaudited financial information for the nine months ended September 30, 2023, ensuring compliance with applicable accounting standards[68] Strategic Outlook - The company believes its diversified business segments will enhance sustainable growth capabilities amid challenging market conditions[42] - The company plans to continue strategic adjustments and optimize resource utilization to ensure core business resilience[42] - The company remains vigilant and will prudently manage operational costs and business growth risks in the face of an uncertain global economic recovery[42] Other Information - There were no significant acquisitions or disposals of subsidiaries during the nine months ended September 30, 2023[38] - No purchase, sale, or redemption of the company's listed securities occurred during the nine months ended September 30, 2023[59] - The company has a stock option plan with 40,000,000 options available for issuance, representing approximately 7.0% of the issued shares as of September 30, 2023[61] - No stock options were granted during the nine months ended September 30, 2023, and there were no unexercised options as of that date[64]
官酝控股(08513) - 2023 Q3 - 季度财报